Literature DB >> 22482863

Usefulness of lung impedance-guided pre-emptive therapy to prevent pulmonary edema during ST-elevation myocardial infarction and to improve long-term outcomes.

Michael Shochat1, Avraham Shotan, David S Blondheim, Mark Kazatsker, Iris Dahan, Aya Asif, Ilia Shochat, Paul Rabinovich, Yoseph Rozenman, Simcha R Meisel.   

Abstract

Patients sustaining an ST-segment elevation myocardial infarction (STEMI) frequently develop pulmonary congestion or pulmonary edema (PED). We previously showed that lung impedance (LI) threshold decrease of 12% to 14% from baseline during admission for STEMI marks the onset of the transition zone from interstitial to alveolar edema and predicts evolution to PED with 98% probability. The aim of this study was to prove that pre-emptive LI-guided treatment may prevent PED and improve clinical outcomes. Five hundred sixty patients with STEMI and no signs of heart failure underwent LI monitoring for 84 ± 36 hours. Maximal LI decrease throughout monitoring did not exceed 12% in 347 patients who did not develop PED (group 1). In 213 patients LI reached the threshold level and, although still asymptomatic (Killip class I), these patients were then randomized to conventional (group 2, n = 142) or LI-guided (group 3, n = 71) pre-emptive therapy. In group 3, treatment was initiated at randomization (LI = -13.8 ± 0.6%). In contrast, conventionally treated patients (group 2) were treated only at onset of dyspnea occurring 4.1 ± 3.1 hours after randomization (LI = -25.8 ± 4.3%, p <0.001). All patients in group 2 but only 8 patients in group 3 (11%) developed Killip class II to IV PED (p <0.001). Unadjusted hospital mortality, length of stay, 1-year readmission rate, 6-year mortality, and new-onset heart failure occurred less in group 3 (p <0.001). Multivariate analysis adjusted for age, left ventricular ejection fraction, risk factors, peak creatine kinase, and admission creatinine and hemoglobin levels showed improved clinical outcome in group 3 (p <0.001). In conclusion, LI-guided pre-emptive therapy in patients with STEMI decreases the incidence of in-hospital PED and results in better short- and long-term outcomes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22482863     DOI: 10.1016/j.amjcard.2012.03.009

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Derivation of baseline lung impedance in chronic heart failure patients: use for monitoring pulmonary congestion and predicting admissions for decompensation.

Authors:  Michael Shochat; Avraham Shotan; David S Blondheim; Mark Kazatsker; Iris Dahan; Aya Asif; Ilia Shochat; Aaron Frimerman; Yoseph Rozenman; Simcha R Meisel
Journal:  J Clin Monit Comput       Date:  2014-09-06       Impact factor: 2.502

2.  Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  David J Webb; Blai Coll; Hiddo J L Heerspink; Dennis Andress; Yili Pritchett; John J Brennan; Mark Houser; Ricardo Correa-Rotter; Donald Kohan; Hirofumi Makino; Vlado Perkovic; Giuseppe Remuzzi; Sheldon W Tobe; Robert Toto; Robert Busch; Pablo Pergola; Hans-Henrik Parving; Dick de Zeeuw
Journal:  Drugs R D       Date:  2017-09

3.  Prediction of readmissions and mortality in patients with heart failure: lessons from the IMPEDANCE-HF extended trial.

Authors:  Michael Kleiner Shochat; Marat Fudim; Avraham Shotan; David S Blondheim; Mark Kazatsker; Iris Dahan; Aya Asif; Yoseph Rozenman; Ilia Kleiner; Jean Marc Weinstein; Gurusher Panjrath; Paul A Sobotka; Simcha R Meisel
Journal:  ESC Heart Fail       Date:  2018-08-10

Review 4.  Should we overcome the resistance to bioelectrical impedance in heart failure?

Authors:  Stephen J Hankinson; Charles H Williams; Van-Khue Ton; Stephen S Gottlieb; Charles C Hong
Journal:  Expert Rev Med Devices       Date:  2020-07-13       Impact factor: 3.166

5.  Preventive treatment of alveolar pulmonary edema of cardiogenic origin.

Authors:  Gideon Charach; Michael Shochat; Alexander Rabinovich; Oded Ayzenberg; Jacob George; Lior Charach; Pavel Rabinovich
Journal:  J Geriatr Cardiol       Date:  2012-12       Impact factor: 3.327

6.  Marital status shows a strong protective effect on long-term mortality among first acute myocardial infarction-survivors with diagnosed hyperlipidemia--findings from the MONICA/KORA myocardial infarction registry.

Authors:  Philip Andrew Quinones; Inge Kirchberger; Margit Heier; Bernhard Kuch; Ines Trentinaglia; Andreas Mielck; Annette Peters; Wolfgang von Scheidt; Christa Meisinger
Journal:  BMC Public Health       Date:  2014-01-30       Impact factor: 3.295

7.  Internal thoracic impedance - a useful method for expedient detection and convenient monitoring of pleural effusion.

Authors:  Gideon Charach; Olga Rubalsky; Lior Charach; Alexander Rabinovich; Ori Argov; Ori Rogowski; Jacob George
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.